好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | H213 - Can I Write Better Than AI? (Wellness Hub)

Wednesday 04/09/25
01:15 PM - 02:00 PM PDT Add To Calendar
San Diego Convention Center | Sails Pavilion: Bayside
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (Wellness)
Heidi G. Moawad, MD, Ludwig Gutmann, MD, FAAN, Lealani M. Acosta, MD, MPH, FAAN
General Neurology
Participants should understand how narrative and medicine can enhance wellness and decrease burnout, nalyze a piece of creative writing and discuss its impact, discuss the role of artificial intelligence (AI) and influence on creative writing, and employ audience engagement to respond to a creative writing prompt and contrast with one written by AI.
No CME available
Interpersonal and Communication Skills, Professionalism
Introductory
Artificial Intelligence
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:15 PM - 02:00 PM PDT Speaker Can I Write Better Than AI?
Heidi G. Moawad, MD, Ludwig Gutmann, MD, FAAN, Lealani M. Acosta, MD, MPH, FAAN
Faculty Disclosures
Heidi G. Moawad, MD Dr. Moawad has nothing to disclose.
Ludwig Gutmann, MD, FAAN Dr. Gutmann has a non-compensated relationship as a senior consulting editor (Humanities) with NEUROLOGY that is relevant to AAN interests or activities.
Lealani M. Acosta, MD, MPH, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.